Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 206667
Company: SETON PHARMS
Company: SETON PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PENTAMIDINE ISETHIONATE | PENTAMIDINE ISETHIONATE | 300MG/VIAL | FOR SOLUTION;INHALATION | Prescription | AN | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/24/2019 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/206667Orig1s000ltr.pdf |
PENTAMIDINE ISETHIONATE
FOR SOLUTION;INHALATION; 300MG/VIAL
TE Code = AN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
NEBUPENT | PENTAMIDINE ISETHIONATE | 300MG/VIAL | FOR SOLUTION;INHALATION | Prescription | Yes | AN | 019887 | FRESENIUS KABI USA |
PENTAMIDINE ISETHIONATE | PENTAMIDINE ISETHIONATE | 300MG/VIAL | FOR SOLUTION;INHALATION | Prescription | No | AN | 206667 | SETON PHARMS |
PENTAMIDINE ISETHIONATE | PENTAMIDINE ISETHIONATE | 300MG/VIAL | FOR SOLUTION;INHALATION | Prescription | No | AN | 206983 | X-GEN PHARMS INC |